FDA Cites Eli Lilly for New Quality-control Problems at Drug Factory in New Jersey
-Reuters Citing FDA Document
Despite Advancement, Benefits From Alzheimer’s Drugs May Be Limited, Say Researchers
Recently, Biogen Inc (NASDAQ:BIIB) and Eisai Co (OTC: ESALY) announced encouraging data from the most-watched Alzheimer’s therapies in the clinic. Lecanemab cleared accumulations…
Eli Lilly’s Obesity Drug, Tirzepatide, Fast Tracked In US; Rolling Submission To Start This Year
The FDA has granted Fast Track designation for Eli Lilly And Co’s (NYSE: LLY) tirzepatide for adults with obesity or overweight with weight-related…
Lilly Receives U.S. FDA Fast Track Designation For Tirzepatide For The Treatment Of Adults With Obesity, Or Overweight With Weight-related Comorbidities
Eli Lilly and Company (NYSE:LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of tirzepatide for the treatment of adults with obesity, or
What Fast Food And Entertainment Giants Did Traders Pick For CNBC’s Fast Money Call Of The Day
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors.
The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined using Benzinga Pro’s News Tool, which can be accessed on any workstation.
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers
PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
Netflix, Biogen And Other Big Gainers From Wednesday
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
Thermo Fisher’s Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers
The FDA approved Thermo Fisher Scientific Inc’s (NYSE:TMO) Oncomine Dx Target Test as a companion diagnostic (CDx) to select patients with RET-fusion…